A professional working in a pharmaceutical establishment. | Photo Credit: BL companies
Wanbury Limited’s Board of Directors has approved key financial decisions, including raising ₹175 crore through non-convertible debentures (NCDs) and granting 2,00,000 stock options under its ESOP 2016 scheme.
The shares of Wanbury Limited were trading at ₹222.38 down by ₹2.31 or 1.03 per cent on the NSE today at 11.55 am.
The company will issue secured, unrated, unlisted and redeemable NCDs on a private placement basis to Emerging India Credit Opportunities Fund II. The tenure for the debentures is set at 60 months, with a fixed coupon rate, and repayment due at the end of the term. The funds will be used for refinancing high-cost debt, capital expenditure and working capital needs.
Additionally, the board granted 2,00,000 stock options to eligible employees, vesting over three years in a mix of loyalty and performance-based allocations. The exercise price is ₹10 per share, with a two-year window for exercising vested options.
Wanbury also reported its unaudited financial results for Q3 and the nine-month period ending December 31, 2024. While revenue for the quarter stood at ₹13,345.18 lakh, the net profit was ₹121.77 lakh, reflecting a decline from the previous quarter’s ₹801.85 lakh due to a planned 30-day shutdown of its Tanuku facility for major upgrades.
The company remains optimistic about future growth, citing the successful clearance of an ANVISA inspection at its Tanuku plant.
Published on February 13, 2025
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.